| Current strategies for the design of PROTAC linkers: a critical review RI Troup, C Fallan, MGJ Baud Exploration of Targeted Anti-tumor Therapy 1 (5), 273, 2020 | 209 | 2020 |
| A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes MGJ Baud, E Lin-Shiao, T Cardote, C Tallant, A Pschibul, KH Chan, ... Science 346 (6209), 638-641, 2014 | 161 | 2014 |
| Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets MGJ Baud, T Leiser, P Haus, S Samlal, AC Wong, RJ Wood, V Petrucci, ... Journal of medicinal chemistry 55 (4), 1731-1750, 2012 | 107 | 2012 |
| Toward photopharmacological antimicrobial chemotherapy using photoswitchable amidohydrolase inhibitors CE Weston, A Krämer, F Colin, O Yildiz, MGJ Baud, FJ Meyer-Almes, ... ACS infectious diseases 3 (2), 152-161, 2017 | 90 | 2017 |
| Dual wavelength asymmetric photochemical synthesis with circularly polarized light RD Richardson, MGJ Baud, CE Weston, HS Rzepa, MK Kuimova, ... Chemical Science 6 (7), 3853-3862, 2015 | 71 | 2015 |
| Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines MGJ Baud, MR Bauer, L Verduci, FA Dingler, KJ Patel, DH Roy, ... European journal of medicinal chemistry 152, 101-114, 2018 | 68 | 2018 |
| Is NMR fragment screening fine-tuned to assess druggability of protein–protein interactions? DM Dias, I Van Molle, MGJ Baud, C Galdeano, CFGC Geraldes, A Ciulli ACS medicinal chemistry letters 5 (1), 23-28, 2014 | 68 | 2014 |
| Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs MR Bauer, RN Jones, MGJ Baud, R Wilcken, FM Boeckler, AR Fersht, ... ACS chemical biology 11 (8), 2265-2274, 2016 | 65 | 2016 |
| New synthetic routes to triazolo-benzodiazepine analogues: expanding the scope of the bump-and-hole approach for selective bromo and extra-terminal (BET) bromodomain inhibition MGJ Baud, E Lin-Shiao, M Zengerle, C Tallant, A Ciulli Journal of medicinal chemistry 59 (4), 1492-1500, 2016 | 60 | 2016 |
| Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53 AC Joerger, MR Bauer, R Wilcken, MGJ Baud, H Harbrecht, TE Exner, ... Structure 23 (12), 2246-2255, 2015 | 59 | 2015 |
| Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition AC Runcie, M Zengerle, KH Chan, A Testa, L van Beurden, MGJ Baud, ... Chemical Science 9 (9), 2452-2468, 2018 | 42 | 2018 |
| Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy V Chasov, R Mirgayazova, E Zmievskaya, R Khadiullina, A Valiullina, ... Frontiers in Oncology 10, 2020 | 38 | 2020 |
| Luminescent Lanthanide Helicates Self-Assembled from Ditopic Ligands Bearing Phosphonic Acid or Phosphoester Units AS Chauvin, S Comby, M Baud, C De Piano, C Duhot, JCG Bünzli Inorganic chemistry 48 (22), 10687-10696, 2009 | 38 | 2009 |
| Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors MGJ Baud, T Leiser, V Petrucci, M Gunaratnam, S Neidle, ... Beilstein journal of organic chemistry 9 (1), 81-88, 2013 | 34 | 2013 |
| Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C JR Stephenson Clarke, LR Douglas, PJ Duriez, DI Balourdas, AC Joerger, ... ACS Pharmacology & Translational Science 5 (11), 1169-1180, 2022 | 32 | 2022 |
| New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation MGJ Baud, T Leiser, FJ Meyer-Almes, MJ Fuchter Organic & Biomolecular Chemistry 9 (3), 659-662, 2011 | 31 | 2011 |
| Horil Roy, D.; Joerger, AC; Fersht, AR Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines MGJ Baud, MR Bauer, L Verduci, FA Dingler, KJ Patel Eur. J. Med. Chem 152, 101-114, 2018 | 28 | 2018 |
| Kinetic method for the large-scale analysis of the binding mechanism of histone deacetylase inhibitors C Meyners, MGJ Baud, MJ Fuchter, FJ Meyer-Almes Analytical biochemistry 460, 39-46, 2014 | 21 | 2014 |
| Highly Ligand Efficient and Selective N‐2‐(Thioethyl) picolinamide Histone Deacetylase Inhibitors Inspired by the Natural Product Psammaplin A MGJ Baud, P Haus, T Leiser, FJ Meyer‐Almes, MJ Fuchter ChemMedChem 8 (1), 149-156, 2013 | 19 | 2013 |
| Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale MA McCoy, D Spicer, N Wells, K Hoogewijs, M Fiedler, MGJ Baud Journal of medicinal chemistry 65 (10), 7246-7261, 2022 | 16 | 2022 |
